Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy

JAMA

Volumn 280, Issue 13, 1998, Pages 1168-1172

  Preston, Richard A ^a   Materson, Barry J ^a   Reda, Domenic J ^b   Williams, David W ^b   Hamburger, Robert J ^c   Cushman, William C ^d   Anderson, Robert J ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b HINES VA HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CAPTOPRIL; CLONIDINE; DILTIAZEM; HYDROCHLOROTHIAZIDE; PRAZOSIN;

AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG RESPONSE; HUMAN; HYPERTENSION; PLASMA RENIN ACTIVITY; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; TREATMENT OUTCOME;

EID: 0032494409     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.13.1168     Document Type: Article

References (24)

1. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1997;157: 2413-2446.
2. Weber MA, Laragh JH. Hypertension: steps forward and steps backward: the Joint National Committee fifth report. Arch Intern Med. 1993; 153:149-152.
3. Tobian L, Brunner HR, Cohn JN, et al. Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V consensus guidelines. Am J Hypertens. 1994;7(pt 1):859-872.
4. Hypertension Detection and Follow-up Program Cooperative Group. The Hypertension Detection and Follow-up Program: a progress report. Circ Res. 1977;40(suppl I):I-106-I-109.
5. Laragh JH, Sealey JE. Renin system understanding for analysis and treatment of hypertensive patients: a means to quantify the vasoconstrictor elements, diagnose curable renal and adrenal causes, assess risk of cardiovascular morbidity, and find the best-fit drug regimen. In: Laragh JH, Brenner BM. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Ltd; 1995:1813-1836.
6. Blumenfeld JD, Mann SJ, Laragh JH. Clinical evaluation and differential diagnosis of the individual hypertensive patient. In: Laragh JH, Brenner BM. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Ltd; 1995:1897-1911.
7. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of renin/sodium profile with risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991;324:1098-1104.
8. Laragh JH. Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int. 1993;44:1163-1175.
9. Laragh JH. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke). J Hum. Hypertens. 1995;9:385-390.
10. Laragh JH. The renin system and four lines of hypertension research. Hypertension. 1992;20:267-279.
11. Materson BJ, Reda DJ, Cushman WC, et al. Single drug therapy in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
12. Materson BJ, Reda DJ. Correction: single-drug therapy for hypertension in men [letter]. N Engl J Med. 1994;330:1689.
13. Materson BJ, Reda DJ, Cushman WC. Department of Veterans Affairs single-drug therapy of hypertension study: revised figures and new data. Am J Hypertens. 1995;8:189-192.
14. Haber E, Koerner T, Page LB. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969; 29:1349-1355.
15. Hamburger RJ, Flamenbaum W. Renin angiotensin axis. In: Breslin DJ, ed. Renovascular Hypertension. Baltimore, Md: Williams & Wilkins; 1982:1-29.
16. Sealey JE, Laragh JH. Radioimmunoassay of plasma renin activity. Semin Nucl Med. 1975;5: 189-262.
17. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med. 1977;2:1079-1092.
18. Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Vaughn ED Jr. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med. 1972;52:633-652.
19. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med. 1973;55:261-274.
20. Case DB, Wallace JM, Keim HJ, Weber MA, Sealey JE, Laragh JH. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med. 1977;296:641-646.
21. Woolson RF. Statistical Methods for the Analysis of Biomedical Data. New York, NY; John Wiley & Sons Inc; 1987.
22. Grizzle JE, Starmer CF, Koch GG. Analysis of categorical data by linear models. Biometrics. 1969; 25:489-504.
23. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
24. SAS Institute Inc. SAS/STAT User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute; 1989.